Formulation of a Psychedelic for Depression
Led by Dr. David Feifel, MD, PhD, Kadima is San Diego's premier psychedelic research institute and a mental health clinic providing advanced, evidence-based treatments.
We are currently enrolling for a clinical trial that is investigating the effects of VLS-01, a formulation of a psychedelic, on Treatment-Resistant Depression (TRD).
This study is conducted under strict medical supervision and participation is completely legal.
You may qualify if you:
are 18-65 years old
Have been diagnosed with clinical depression by a licensed mental health professional
Have tried 2+ antidepressant medications
Can attend in-person visits at our La Jolla clinic
Enroll in just a few steps!
Complete a short eligibility survey
Complete a screening call with our study recruiter
If eligible and consenting, you will be enrolled in the study!
If you know someone struggling with Depression who may be interested in this opportunity, please share this with them.
David Feifel, MD, PhD
Professor Emeritus, UCSD · Founder, Kadima Neuropsychiatry
This study is done at Kadima Neuropsychiatry Institute in La Jolla, CA and is sponsored by atai Life Sciences.
A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled Trial to Assess the Efficacy, Safety, and Tolerability of Repeated Doses of VLS-01 Buccal Film in Participants With Treatment Resistant Depression.